Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion - Twist Bioscience (NASDAQ:TWST)

Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing revenue and profit margins.

Related Keywords

,Goldman Sachs ,Twist Bioscience Corp ,Express Genes ,Agilent Technologies Inca ,Total Addressable Market ,